DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sanathan Textiles Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 52 min ago·7 Oct 2026, 7:42 am

Sanathan Textiles

Sanathan Textiles has informed stock exchanges that it has received a Certificate of Compliance under SEBI Regulation 74(5). This regulation mandates that listed companies must maintain a specific level of funds in their designated investor protection funds. The certificate confirms that the company has met these financial requirements for the relevant period.

For investors, this development is a routine procedural update rather than a market-moving event. It serves as a formal confirmation that the company is adhering to SEBI's corporate governance and investor protection norms. This helps maintain transparency and ensures that the company's operations remain in compliance with regulatory standards.

Investors should view this as a standard compliance filing. There are no immediate implications for the company's financial health or stock performance. The focus should remain on the company's core business activities and future earnings reports.